RPS6KB1 and Huntington disease: Based on this, and the studies showing that treatment with rapamycin and its analogues can ameliorate HD pathogenesis, we hypothesized that loss of S6k1 may alleviate the symptoms observed in the R6/2 mouse model of HD.